Contrapunto Films - Los Angeles since Dec 2012
Writer (Principal)*
Launch Education Group 2010 - 2013
Tutor
Carol Baum Productions 2011 - 2011
Assistant to Ms. Baum
Warner Bros. (The CW's Gossip Girl) 2010 - 2011
Writers' PA
Cornell Daily Sun Mar 2008 - Mar 2009
Arts and Entertainment Editor
Education:
Cornell University 2006 - 2010
BA, Media Studies, Sexuality Studies, Cultural Anthropology
Evanston Township High School 2001 - 2005
Honor & Awards:
Graduated summa cum laude from Cornell in May 2010
Co Writer on short film script, DREAM CAFFEINE, which was accepted into the AFI's Directing Workshop for Women.
Languages:
Hebrew Nepali (Conversational) Italian (Conversational)
Director Of Corporate Archives And History At Under Armour
Senior Director of Apparel Development at Under Armour, Director of Womens and Girls Development at Under Armour
Location:
Baltimore, Maryland
Industry:
Apparel & Fashion
Work:
Under Armour since Jun 2007
Senior Director of Apparel Development
Under Armour since Jun 2006
Director of Womens and Girls Development
Fila 1992 - 1999
Product Developer
Education:
Philadelphia University 1989 - 1991
Bachelor of Arts (BA), Fashion/Apparel Design
South Elementary School Ithaca MI 1971-1977, Charleston Elementary School Wellsboro PA 1978-1978, Claysburg-Kimmel Elementary School Claysburg PA 1981-1981
Community:
Melinda Osterhout, Sara Woodard, Amber Phipps, Valorie Seward, Robert Tice, Daniel Bowen
"People with moderate to severe atopic dermatitis cope with intense, sometimes unbearable symptoms that can impact them for most of their lives," Julie Block, president and CEO of the National Eczema Association, said in a statement provided by the company.
Date: Mar 28, 2017
Category: Business
Source: Google
Pfizer (PFE) Confirms FDA Approval for EUCRISATM for Eczema
After many years without new therapies, this is an exciting day for those living with mild to moderate eczema and their caregivers, said Julie Block, President and Chief Executive Officer of the National Eczema Association.
Date: Dec 15, 2016
Category: Health
Source: Google
Regeneron and Sanofi Announce that Dupilumab Has Received FDA ...
oderate-to-severe atopic dermatitis is a debilitating, life-altering disease with very limited treatment options. Many patients suffer for years with widespreadinflamed skin, intense itch, sleep disturbances and other challenges,"said Julie Block, Chief Executive Officer, National Eczema Association. "
"It just seems like this time of year since it's the new year, people want to start fresh on something or something didn't work out last year, hoping the new year will be better," said fitness trainer Julie Block. "That's why they want a New Year's resolution or goal in mind."